Authors
Latest:
The Importance of Collaboration Between Mohs Surgeons and UrologistsCaleb Kovell, MD and Junqian Zhang, MD demonstrated how teaming up increases the likelihood for positive patient outcomes in Mohs cases on the genitalia and perianal region.
Latest:
Clinical Pearls: PDPA’s 5th Annual Keystone Dermatology ConferenceJamie Restivo, MPAS, PA-C, shares some insights from the 5th Annual Keystone Dermatology Conference held from October 17 to 19 in Philadelphia, Pennsylvania.
Latest:
Jeff Stark, MD: Discussing Bimzelx’s Efficacy and Future in Treating Inflammatory Skin DiseasesStark highlighted Bimzelx’s role in treating psoriasis and HS, introduced the BE BOLD study for PsA, and looked to future innovation in inflammatory skin disease.
Latest:
Key Takeaways For the Management of Plaque PsoriasisExperts in dermatology share closing thoughts on the management of plaque psoriasis.
Latest:
Frontline Forum Part 4: Improving Basal Cell Carcinoma ManagementIn the final part of this Frontline Forum series, Brent Moody, MD; Sarah Arron, MD, PhD; Justine Cohen, DO; Emily Ruiz, MD, MPH; and Todd Schlesinger, MD, review 4 real-world clinical cases of BCC and the treatments they utilized.
Latest:
SFA-002 Shows Promise in Early Clinical Trial Psoriasis CohortsStefan Weiss, MD, MBA, explains next steps for the oral treatment after the completion of phase 1b enrollment.
Latest:
Deucravacitinib: A Year in ReviewAs deucravacitinib surpasses its 1-year milestone since approval, clinicians continue to monitor its real-world performance among patients.
Latest:
BCC Patient Case ImpressionsSherrif F. Ibrahim, MD, PhD, and Vishal Patel, MD, FAAD, FACMS, provide initial impressions of the case and discuss the use of immune checkpoint inhibitors.
Latest:
SPROUT Trial Highlights Benefits of Apremilast for Pediatric PsoriasisThe trial showcased the continued efficacy of apremilast, with 2-year data on the forefront.
Latest:
An Increase in Skin Cancer Calls for an Increase in Treatment OptionsTo address the increased rates of skin cancer while keeping unique patient needs top of mind, there is a pressing need to increase options for treatment.
Latest:
The Dx and Rx of Congenital Malalignment Syndrome in ChildrenCongenital malalignment syndrome is a nail disorder caused by the lateral rotation of the nail matrix.
Latest:
Evan Rieder, MD: Equipping Patients With Tools for Skin AcceptanceFollowing this week's Science of Skin media roundtable hosted by AbbVie, panelist and dual-board certified dermatologist and psychiatrist Evan Rieder, MD, discusses the relationship between chronic skin conditions and mental health.
Latest:
Tailoring Aesthetic Treatments for Patients With Skin of ColorOmer Ibrahim, MD, discusses the nuances of aesthetic procedures for patients with skin of color and the importance of tailored treatments, safety, and improved clinician education.
Latest:
Select Medical Software Based on Your Practice’s Life Cycle StageThough providers probably can use any type of medical software, the financial resources they are able to invest in medical solutions differ significantly based on the type of practice.
Latest:
Nonsurgical Treatments for Advanced BCC ManagementPanelists discuss how emerging nonsurgical options such as hedgehog pathway inhibitors, immune checkpoint inhibitors, and photodynamic therapy are expanding treatment possibilities for patients with advanced basal cell carcinoma (BCC), particularly for those unsuitable for or unresponsive to traditional surgical interventions.
Latest:
Addressing Cutaneous Blisters and Chronic Bullous Disorders With Megan Noe, MD, MPH, MSCEMegan Noe, MD, MPH, MSCE, reviews best practices for treating patients with cutaneous blisters and managing chronic bullous disorders.
Latest:
Q&A: Late-Breaking REMIX-1 and REMIX-2 Data Demonstrated Efficacy of Remibrutinib in Chronic Spontaneous UrticariaAllergist immunologist Giselle Mosnaim, MD, recently spoke with Dermatology Times to discuss late-breaking phase 3 REMIX-1 and REMIX-2 data presented at the American Academy of Allergy, Asthma, and Immunology Annual Meeting.
Latest:
Christophe Piketty, MD, PhD: The Role of Nemolizumab in Addressing Unmet Needs of Patients With AD and PNChristophe Piketty, MD, PHD, provides a deeper look at the promise of nemolizumab in addressing unmet needs faced by patients with atopic dermatitis and prurigo nodularis.
Latest:
Rare Autoimmune Disorder Linked With Increased Risk of Certain Skin CancersPatients with mucous membrane pemphigoid face increased skin cancer risks, particularly squamous cell carcinoma, highlighting the need for vigilant screening.
Latest:
In Skin Cancer, Immunotherapy May Lead to Chronic EffectsResearch showed that many patients with skin cancer who had been treated using immunotherapy, such as immune checkpoint inhibition, experienced chronic side effects.
Latest:
Denise Dajles, DEng, MSc, Ushers in a New Era at Cytrellis Biosystems, Looks to Future of Aesthetics IndustryCytrellis' new president and CEO discusses bridging surgery and innovation in aesthetics.
Latest:
Insight from Anant Madabhushi, PhD on AI in Dermatologic CareHis keynote speech at ACMS focused on artificial intelligence for precision medicine and cancer diagnosis.
Latest:
The Future of AI-Powered SkincareAnastasia Georgievskaya reflects on the success of SkinGPT and reveals upcoming plans and potential advancements in artificial intelligence and dermatology.
Latest:
National Eczema Association Expands Visual Guide to Address Skin Tone DisparitiesWendy Smith Begolka, MBS, and Renata Block, MMS, PA-C discuss the NEA's expanded eczema visual guide and upcoming Chicago event to support diverse patient communities.
